Chief Operating Officer · CME GROUP INC. (CME)

Julie Holzrichter

A named executive officer of CME in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,420,987

Salary $525,000Stock awards $1,653,148

FY2022: $3,290,236

3rd of 6 named executive officers at CME by FY2023 total.

6 named officers on file for CME, FY2023

Julie Holzrichter’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 11 equity grants, each cited to its filing
  • CME’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CME’s whole pay program stands against its peers

  • CME’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CME→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 18, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Julie Holzrichter’s full pay file as a PDF — free

More than this page: up to 10 years of Julie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Julie Holzrichter compensation by year

CME Summary Compensation Table · all 6 fiscal years held
In US dollars, as CME reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023
Salary$475,000$500,000$500,000$500,000$525,000$525,000
Bonus$0$0$0$0$0$0
Stock awards$1,849,742$1,654,179$1,822,123$1,926,919$1,644,595$1,653,148
Option awards$0$0$0$0$0$0
Non-equity incentive$830,077$610,451$532,500$730,450$1,027,921$1,037,873
Pension and deferred compensation$2,091$87,941$75,120$28,605$0$78,113
All other$79,037$146,759$82,021$75,240$92,720$126,853
Total$3,235,947$2,999,330$3,011,764$3,261,214$3,290,236$3,420,987

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CME GROUP INC. DEF 14A filed March 18, 2024, accession 0001156375-24-000018, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CME GROUP INC. filed document, accession 0001156375-24-000018. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2024.

$3.2M
$3.0M
$3.0M
$3.3M
$3.3M
$3.4M
FY18
FY19
FY20
FY21
FY22
FY23
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU3,808$801,965—
RSU3,096$652,018—
RSU2,064$434,678—
RSU1,984$417,830—
RSU1,115$234,819—

Per the Outstanding Equity Awards at Fiscal Year-End table in CME GROUP INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

4 Form 4 lines since the FY2023 proxy (filed March 18, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-09-16Grant or award—3,604$218.5340,437
2024-09-15Tax withholding—1,583$216.9936,833
2024-03-15Tax withholding—3,350$217.5038,416
2024-03-15Grant or award—7,560$217.5041,766

The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Change-in-control & termination

estimated payments CME discloses, by trigger · FY2023
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Voluntary resignation$0$2,604,911$0$2,604,911
Involuntary termination without cause$868,269$1,592,136$7,194$2,467,599
Change in control, no termination$868,269$6,205,961$7,194$7,081,424
Death$0$6,205,961$0$7,243,834
Disability$0$6,205,961$0$7,243,834

Per the Potential Payments Upon Termination or Change in Control table in CME GROUP INC.'s FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.

CME’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Terrence DuffyChairman and Chief Executive Officer$23,468,000
John PietrowiczFormer Chief Financial Officer$6,232,040
Julie Holzrichter · this pageChief Operating Officer$3,420,987
Derek SammannGlobal Head of Commodities, Options & International Markets 8$3,412,041
Sunil CutinhoChief Information Officer$3,395,035
Lynne FitzpatrickChief Financial Officer 7$2,559,740

The full CME compensation record

free company brief

This page is one person within CME's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CME proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CME's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Julie Holzrichter's compensation dossier · One-time report. No refunds.